Lv41
580 积分 2023-06-06 加入
Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers
2小时前
已完结
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: a nationwide study
8天前
已完结
Concurrent therapy with dupilumab and infliximab for atopic dermatitis and Crohn's disease
8天前
已关闭
Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis
9天前
已完结
Two studies of nerve growth factor (NGF) inhibitors implemented a rigorous mitigation plan to exclude OA patients with a risk of joint collapse, but it was still not enough!
21天前
已完结
Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum
2个月前
已完结
Brodalumab for the treatment of refractory Sweet syndrome
2个月前
已完结
Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study
2个月前
已完结
Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study
3个月前
已完结
Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa
3个月前
已完结
皖公网安备34019202002308
